https://www.naturalnews.com/2021-04-26-plant-based-vaccine-herbs-immune-system-coronavirus.html

Natural News) Canadian company Medicago has developed a plant-based vaccine for the Wuhan coronavirus (COVID-19). The two-dose vaccine uses virus-like particles (VLP) grown in a tobacco shrub to confer immunity against COVID-19.

VLPs are molecules that closely resemble a virus. They are not infectious since they do not contain genetic material. Vaccines that use VLPs train the immune system to recognize a virus and launch an attack if a person gets infected.

Medicago’s vaccine is different from all authorized COVID-19 vaccines. Whereas other vaccines target only the spike protein, the molecule used by the coronavirus to infect host cells, the plant-based shot uses VLPs that resemble the overall structure of the Wuhan coronavirus.

A small Phase 1 study shows that recipients of the vaccine produce 10 times as many antibodies as people who have had COVID-19. The data also indicate no links to blood clots, which have been reported in people inoculated with the Johnson & Johnson and AstraZeneca vaccines.

“Thus far, the safety profile from the Medicago pre-clinical data as well as the Phase 1 and Phase 2 data has identified nothing concerning regarding blood clotting or any other safety flags,” Dr. Mark Carlson, the principal investigator for Be Well Clinical Studies, the Nebraska arm of the trial, told KETV.

The vaccine can be distributed easily since it does not have to be stored at freezing temperatures. In addition, it can be manufactured quickly for less than the cost of other vaccines, according to Dr. Matthew Hong of Wake Research in North Carolina, which is also conducting trials for Medicago.

“All you have to do is extract the spike protein from the plant from the leaves, and you have the vaccine,” Hong told ABC News 11. “You don’t need all the background and all the other support systems.”

The firm is currently recruiting 30,000 volunteers for a late-stage trial. To qualify, volunteers must be aged 18 years or older and have not had or been vaccinated for COVID-19. This is increasingly difficult because around 50.7 of the adult American population has received at least one dose.